Syngene International Ltd.

Premium

Healthcare

25 September, 2023

TPG-backed firm to absorb Indian drugmaker's contract development biz, go public

An Indian biopharmaceutical company that counts private equity firm TPG as an investor will absorb a local drugmaker’s contract development ......

Premium

Healthcare

24 July, 2023

Advent may rope in new investor for Bharat Serums with neat valuation markup

Mumbai-based biopharmaceutical company Bharat Serums, controlled by private equity major Advent International, is looking to onboard new investor(s) for a ......

Premium

Healthcare

11 September, 2017

Temasek bets on another Indian healthcare company

Singapore state investment firm Temasek Holdings has picked up a minority stake in an Indian drug research company, thereby increasing ......

Premium

Healthcare

18 May, 2017

True North makes partial exit from drug research firm with strong gains

Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains ......

Healthcare

04 January, 2016

Syngene names AstraZeneca's Jonathan Hunt CEO

Syngene International Ltd, the research and development unit of biopharmaceutical firm Biocon Ltd, said on Monday it has appointed Jonathan ......

Healthcare

11 August, 2015

IVFA-backed Syngene makes strong market debut, ends day 1 with 24% gain

Syngene International Ltd, the research and development subsidiary of Indian biopharmaceutical major Biocon Ltd, made a strong debut on the ......

Healthcare

29 July, 2015

IVFA-backed Syngene's IPO oversubscribed 31 times

Syngene International Ltd, the research and development subsidiary of Indian biopharmaceutical major Biocon Ltd, saw its initial public offer (IPO) ......

Healthcare

28 July, 2015

Singapore's GIC comes as anchor investor in Syngene; IPO fully covered on day 2

Singapore's GIC, one of the most active sovereign wealth funds in the country, is among the anchor investors which have ......

Healthcare

17 July, 2015

Biocon to open IPO of R&D arm Syngene end of this month, fixes price band

Biopharmaceutical major Biocon Ltd has fixed the price band for the initial public offering (IPO) of its research and development ......

Consumer

15 June, 2015

SEBI clears Prabhat Dairy, Syngene International IPO plans

The capital markets regulator Securities and Exchange Board of India (SEBI) has given its approval to the proposed initial public ......